NOT-CA-03-002: ACTIVITIES TO PROMOTE RESEARCH COLLABORATIONS

Department of Health
and Human Services (HHS)
NIH... Turning Discovery Into Health^®

ACTIVITIES TO PROMOTE RESEARCH COLLABORATIONS

RELEASE DATE:  November 13, 2002

NOTICE:  NOT-CA-03-002

National Cancer Institute (NCI)
 (http://www.nci.nih.gov/)

The Division of Cancer Biology (DCB) of the National Cancer Institute 
announces an eligibility change in the Activities to Promote Research 
Collaboration (APRC) supplement program previously published as NOT-CA-
02-028.  NCI-funded Phase II SBIR and Phase II STTR grantees are now 
eligible to apply for funding under the APRC program.  SBIR/STTR 
grantees may participate as either the leader of a consortium, if 
funded by NCI through DCB, or as a participant in a consortium headed 
by another DCB grantee.  As stated in the Eligibility Requirements 
section of the APRC Guidelines, participants in a consortium, except 
for the lead institution, need not be funded by DCB.  All eligibility 
requirements and budget and administrative limits will apply to any 
consortia that include NCI-funded SBIR/STTR grantees.  Proposals for 
workshops would not be appropriate from SBIR/STTR grantees.  SBIR/STTR 
grantees will be expected to comply with the limitations on 
outsourcing.

A full description of the APRC program and the guidelines can be found 
at the URL: http://www.nci.nih.gov/dcb/APRC2003.htm.  It details the 
opportunities available to DCB grantees for collaborative activities 
funded with administrative supplements to their active grants and the 
mechanisms for requesting these supplements.

Requests for APRC supplemental support will be accepted 2 times this 
year: December 16th and April 15th.  Requests must be submitted as 
described on the web site.

INQUIRIES

Investigators funded by NCI through DCB who are interested in the 
activities described here are highly encouraged to contact their DCB 
Program Director prior to submitting an application.

For further information, contact:

John Sogn, Ph.D.
Deputy Director, Division of Cancer Biology
National Cancer Institute, NIH,
Executive Plaza North, Room 5050
6130 Executive Boulevard
Bethesda, MD 20892-7150
Telephone: (301) 594-8782
FAX: (301) 496-8656
E-mail: [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices